$94 Million is the total value of Wildcat Capital Management, LLC's 13 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 58.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CSGP | Sell | COSTAR GROUP INC | $45,435,000 | -4.2% | 153,007 | -13.5% | 48.34% | +468.3% |
| SRNE | Sell | SORRENTO THERAPEUTICS INC | $6,605,000 | +38.8% | 1,738,232 | -37.9% | 7.03% | +722.8% |
| URGN | Sell | UROGEN PHARMA LTD | $4,738,000 | +11.4% | 127,313 | -5.7% | 5.04% | +560.7% |
| NK | Sell | NANTKWEST INC | $3,632,000 | -80.5% | 808,974 | -76.1% | 3.86% | +15.9% |
| NH | Sell | NANTHEALTH INC | $611,000 | -37.9% | 200,373 | -16.1% | 0.65% | +269.3% |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -15,000 | -100.0% | -0.01% | – |
| EDIT | Exit | EDITAS MEDICINE INC | $0 | – | -41,324 | -100.0% | -0.18% | – |
| FXY | Exit | CURRENCYSHARES JAPANESE YENjapanese yen | $0 | – | -31,245 | -100.0% | -0.48% | – |
| MDXG | Exit | MIMEDX GROUP INC | $0 | – | -500,000 | -100.0% | -1.06% | – |
| CSAL | Exit | UNITI GROUP INC | $0 | – | -410,700 | -100.0% | -1.08% | – |
| EMB | Exit | ISHARES JP MORGAN USD EMERGIjp mor em mk etf | $0 | – | -70,000 | -100.0% | -1.45% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -2,410,034 | -100.0% | -77.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
| UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
| META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
| ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
| GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
| SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
| LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
| PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
| NANTKWEST INC | 17 | Q3 2019 | 22.0% |
| SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
| UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
| Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
| NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
| Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 3 | 2024-04-08 |
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-09 |
| PX14A6G | 2023-11-03 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-07 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.